Market Summery
Acknowledging the impressive growth records, the market perceives
currently, Market Research Future (MRFR) in its recently published study report
asserts that the global Capillary Blood
Collection Devices market share will
register a staggering CAGR of 6.20% from 2022-2030, witnessing the accruals of
approx. 790 Mn. USD by 2030.
Capillary Blood Collection Devices, the equipment used to collect
the blood samplings for diagnosis and test purposes are integral to obtain
high-quality clinical results. These devices are vastly preferred among
clinicians and patients due to its simple and painless blood collection
technique.
Growing prevalence of chronic diseases and disorders such as
vascular, diabetes, and heart diseases drive the market growth, increasing the
demand for diagnosis and the uptake of these devices. Resultantly, the
global capillary blood collection devices market is garnering huge traction,
growing pervasively.
Undoubtedly, technological advancements transpired in the field of
medical devices as a foray to bring more innovations in these devices are
boosting the market growth, escalating the market to the exceeding heights.
Conversely, high prices of these devices is a predominant factor
impeding the market growth. Also, the risk associated with the blood collection
techniques and contaminations are hampering the market growth of the capillary
blood collection devices market. Nevertheless, recent betterments taken place
in these devices as a result of forays of the market players are increasing the
demand for these devices by the physicians and patients, contributing to the
market growth to a great extent, in turn.
Capillary Blood Collection Devices Market – Competitive Landscape
The global market appears to be highly competitive and diversified
with the presence of giant manufacturers of the devices, playing on the global
level. These players are heavily investing in R&D, global expansion,
advanced technologies and product Launch to gain the competitive edge in the
market.
Key Players:
Capillary blood collection devices market players include –
Danaher Corporation, Abbott Laboratories, F. Hoffmann-La Roche AG, Becton
Dickinson and Company, Medtronic Plc., Novo Nordisk A S, Thermo Fisher
Scientific Inc., Terumo Corporation, B. Braun Melsungen AG, HTL-STREFA S.A.,
Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio-One, Owen Mumford Ltd.,
Improve Medical, Nipro, Chengdu Rich Science Industry Co., Ltd., Weigao Group,
Weihai Hongyu Medical Devices, and Medigard. Profiling them in its analysis, MRFR
finds out their strategies keeping them ahead in the market competition.
Capillary Blood Collection Devices Market – Segments
The MRFR analysis is segmented into four key dynamics for the
convenience of the report and enhanced understanding;
By Material
s
: Comprises Glass, Plastic, and Stainless Steel, among others.
By Types of Devices : Warming Devices, Blood
Collecting Tubes & Collector, and Lancets, among others.
By
End-Users
: Hospitals, Clinics, Diagnostic Centers, Home
Diagnostics, and Pathology Laboratories, among others.
By Regions
: North America, Europe, APAC and
Rest-of-the-World.
The Plastic segment by the materials is projected to acquire 42.3%
of the market share which will be the largest share. The segment will register
10.4% CAGR during the review period 2017–2023.
The Blood Collecting Tubes and Collector segment is expected to
acquire 48.4% of the market share over the review period which will be the
largest share based on the types of devices
The Lancets Segment is projected to grow at a CAGR of 10.4%
between 2017–2023.
Capillary Blood Collection Devices Market – Regional Analysis
North America Capillary Blood
Collection Devices market outlook backed
by the presence of well-established players & investments, accounts for the
leading market, globally, holding the largest market share. Companies involved
in the manufacturing of these devices are well capable of delivering a range of
customized solutions. Furthermore, augmented uptake of software solutions for
healthcare administration and availability of complimenting resources drive the
market growth in the region.
Factors substantiating the market growth include growing number of
patients suffering from chronic diseases & disorders that consecutively
augments the demand for diagnosis, increasing demand for technologically
advanced diagnosis and treatment, rising government support and high per capita
health care expenditures in the region. The market value is estimated to settle
at US$ 292.96 Mn. by 2023.
The Europe market stands the second largest market for capillary
blood collection devices, globally, owing to the technological advancement and
the augmented adoption of these devices among the healthcare providers mainly
in the UK, Germany, and France coupled with the resurging economy in the region
which is improving the consumers’ quality of life by increasing their
purchasing power.
The market is expected to demonstrate a healthy growth during the
forecast period owing to the factors such as public & private funding for
R&D, the presence of leading market players and increasing prevalence of
diabetes, in the region.
Additional factors such as the availability of advent &
advanced treatment facilities & healthcare expenditures along with the
growing demand for better healthcare infrastructure are fuelling the market
growth in the region. Also, factors such as the ever increasing
population that is increasingly adopting the sedentary lifestyle are driving
the growth of the Europe market.
The Asia Pacific market stands the third position emerging as one
of the promising markets for Capillary Blood Collection Devices. Factors such
as, availability of new diagnosis and treatment methods, increasing prevalence
of chronic diseases like diabetes and the growing population that is
increasingly gaining awareness towards the benefits of health management,
foster the market growth in the region. The APAC market is estimated to
grow at 10.6% CAGR during 2017–2023.
The Middle East & Africa region, on the other hand, is
expected to experience a plateau phase in the growth primarily due to the
African market where lack of awareness, limited access and availability of
treatment facilities are some of the factors responsible for the restricted
growth. While the Middle East region is expected to a steady growth owing to
the well-developed healthcare sector that is increasingly availing specialty
care centers. UAE among other MEA countries draws the largest market share in the
region.
About US:
Market Research Future (MRFR), enable customers to unravel the
complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
